genia tagger: 227('psilencer', 4)
('plates\\.', 2)
('photoshop', 2)
('mda-mb-231', 93)
('crm197', 8)
('gpcrs', 7)
('human', 11)
('trastuzumab', 3)
('expression\\.', 8)
('protease-activated', 7)
('shrna-expressing', 18)
('proteases', 10)
('1', 766)
('tumor-generated', 4)
('anti-egfr', 4)
('i\\/o', 26)
('transcriptase', 2)
('termed', 5)
('\\>', 24)
('\\?', 71)
('\\<', 27)
('thrombin-', 105)
('kinase', 55)
('receptors', 2)
('metalloprotease', 36)
('factor', 43)
('\\.', 737)
('tfllrnpndk', 18)
('par1\\.', 4)
('extracellular', 4)
('\\(', 368)
('\\)', 367)
('5\\.1', 4)
('epidermal', 8)
('carcinoma\\.', 35)
('1\xe2\x80\x934', 4)
('b', 2112)
('breast', 209)
('membrane-anchored', 2)
('gm6001-treated', 4)
('untreated', 11)
('hematoxylin', 5)
('packaging', 2)
('d', 3154)
('anti-rabbit', 2)
('transferrin', 2)
('proteins', 14)
('prolonged', 10)
('fibroblasts', 20)
('heparin-binding-egf', 1)
('deplete', 4)
('-2', 95)
('sirna-treated', 5)
('control\\.', 3)
('gm6001', 21)
('crm', 11)
('thrombin-induced', 76)
('molecules\\.', 1)
('sequence', 10)
('197', 11)
('toxin-treated', 4)
('transwells', 2)
('fibronectin', 2)
('growth', 64)
('insertion', 4)
('g-protein-coupled', 2)
('subtypes', 2)
('\\/italic', 8)
('elisa', 3)
('matrix', 1)
('factors', 30)
('thrombin', 257)
('cell', 405)
('phosphoinositide', 10)
('immunodeficient', 17)
('serum-starved', 8)
('g-protein', 4)
('pa317', 2)
('-agauuagucuccaucaaua-3', 2)
('media\\.', 2)
('bt549', 9)
('mmp', 2)
('control', 92)
('adam15', 2)
('members', 4)
('3\\.0', 4)
('active', 18)
('invasion\\.', 43)
('104', 4)
('ligand', 27)
('src', 2)
('c', 3343)
('reverse', 4)
('g', 1575)
('-ctacgtccaggagcgcacc-3', 2)
('hmecs', 7)
('herceptin', 1)
('p2', 9)
('gpcr', 14)
('insulin', 2)
('activation\\.', 17)
('factor-', 1)
('mice\\.', 10)
('antibody', 24)
('-aaauuccaguggccaucaa-3', 2)
('software', 2)
('erbb2', 205)
('erbb3', 11)
('rho', 10)
('family', 5)
('invasive', 96)
('nontransformed', 1)
('anti\\-p44\\/42', 5)
('egfr', 224)
('erbb2\\/her2', 12)
('5\xe2\x80\x936', 4)
('dishes\\.', 2)
('tace\\/adam17', 4)
('receptor', 29)
('par2', 18)
('par1', 271)
('sequences', 2)
('anti-phosphotyrosine', 2)
('cells\\.', 36)
('\xc3\x97', 18)
('mammary', 35)
('experiments\\.', 11)
('mmp-1', 1)
('cancer', 37)
('figure', 160)
('thrombin-stimulated', 25)
('tgf-', 3)
('kinases', 3)
('6', 105)
('serum-deprived', 5)
('py99', 5)
('was', 132)
('tyrosine', 61)
('fibroblast-secreted', 4)
('lanes', 12)
('pyk2', 2)
('vehicle', 6)
('heterodimeric', 7)
('anti-par1', 3)
('pars', 4)
('signaling', 81)
('7a', 4)
('7\\.0', 2)
('ligands', 6)
('anti-erbb2', 5)
('p1', 27)
('coagulant', 1)
('17', 8)
('cells', 297)
('control-treated', 4)
('invaded', 3)
('endogenous', 4)
('hydrolysis', 10)
('cytoplasmic', 1)
('assays', 2)
('3t3', 17)
('hb-egf', 10)
('pertussis', 17)
('sirna', 28)
('kinase-1', 3)
('and', 482)
('telomerase', 2)
('par10', 1)
('hepes', 4)
('invitrogen\\.', 2)
('signal-regulated', 3)
('receptor-1', 7)
('epithelial', 14)
('myo', 4)
('immunoblotting\\.', 1)
('protein', 23)
('humanized', 1)
('tumors', 11)
('melanoma', 2)
('mapk', 10)
('par1-induced', 4)
('matrigel-coated', 2)
('noninvading', 2)
('stromal', 8)
('prism', 2)
('5', 102)
('toxin', 23)
('par1-deficient', 45)
('ag1478-treated', 1)
('anti\\-phospho\\-p44\\/42', 5)
('goat', 4)
('adam', 9)
('independent', 9)
('nih', 17)
('erk1\\/2', 53)
('multiple', 9)
('normal', 14)
('transforming', 1)
('residues', 1)
('ix71', 2)
('complexes', 7)
('shown\\.', 1)
('carcinoma', 156)
('erbb4\\.', 1)
('invasion', 133)
('intrinsic', 1)
('tace', 6)
('-ggaagaagccuuauuggua-3', 2)
('sub', 38)
('24-well', 8)
('-thrombin', 2)
('antibodies', 8)
('e', 8335)
('fibroblast-conditioned', 5)
('mitogen-activated', 3)
('matrigel\\.', 2)
('anti-py99', 3)
('lines', 7)
('polyclonal', 6)
('\\/sub', 4)
('nonspecific', 7)
('assessed\\.', 8)
('erbb', 338)
('12', 13)
('anti-epidermal', 1)
('egf', 274)
('surface', 8)


spacy + metamap: 547('', 97221)
('kidney diseases', 2)
('global', 4)
('activated', 27)
('resistance', 1)
('four', 6)
('trastuzumab', 3)
('dish', 8)
('epithelial cells', 14)
('pretreatment', 4)
('environment', 6)
('xenografts', 3)
('crystal violet', 2)
('th', 1239)
('drug discovery', 2)
('cm2', 2)
('immunodeficient', 17)
('2 h', 9)
('activation', 319)
('nodules', 4)
('orthotopic', 8)
('induce', 197)
('g i', 49)
('cellular', 54)
('difference', 3)
('condition', 34)
('chapel', 4)
('progression', 13)
('deficient', 66)
('list', 2)
('prolonged', 10)
('implants', 1)
('melanoma cell', 2)
('small', 6)
('biological', 2)
('gm6001', 21)
('upper', 5)
('findings', 21)
('guidelines', 2)
('cancer patient', 1)
('recruitment', 1)
('invaded', 3)
('insertion', 4)
('agonists', 3)
('her2', 12)
('acid', 2)
('elisa', 3)
('residue', 1)
('sub', 38)
('section', 12)
('cell', 405)
('3h', 8)
('phosphotyrosine', 2)
('new', 5)
('contrast', 12)
('electroporation', 4)
('highly', 8)
('metastases', 4)
('chemiluminescence', 2)
('groups', 2)
('paraffin', 2)
('active', 18)
('anti-egfr', 4)
('legend', 1)
('box', 3)
('trans', 271)
('study', 12)
('amount', 5)
('insulin', 2)
('reagents', 2)
('studies', 42)
('invasiveness', 1)
('family', 5)
('mediator', 6)
('egfr', 224)
('marked', 12)
('conjugated', 2)
('mouse mammary fat pad', 4)
('morphology', 1)
('pore size', 2)
('total', 3)
('use', 57)
('usa', 10)
('positive', 10)
('ctrl', 1)
('two', 5)
('camera', 2)
('vehicle', 6)
('sectioning', 4)
('0\\%', 3)
('populations', 2)
('composite', 2)
('transient', 6)
('rabbit', 2)
('insertion sequence', 2)
('iii', 4)
('insights', 2)
('town', 2)
('high', 18)
('mb', 375)
('ml', 11)
('work', 2)
('modified', 2)
('endogenous', 4)
('hydrolysis', 10)
('phosphoinositide', 10)
('following', 16)
('inhibitor', 18)
('10\\%', 2)
('proteolytic', 16)
('control', 92)
('process', 22)
('bovine pituitary extract', 2)
('agent', 8)
('sample', 2)
('sense', 2)
('nonmetastatic', 2)
('serum', 18)
('mouse', 7)
('s1', 1)
('six', 2)
('ng\\/ml', 2)
('flank', 4)
('animal', 6)
('optimal', 4)
('pathway', 9)
('30 min', 3)
('mas', 2)
('cocktail', 2)
('treatments', 3)
('polycarbonate', 2)
('mediated', 10)
('invasion', 133)
('data', 36)
('response', 10)
('ectopic expression', 3)
('overexpression', 2)
('lines', 7)
('deterioration', 1)
('hb-egf', 10)
('discussion', 2)
('family members', 4)
('metastatic breast cancer', 9)
('shrna', 31)
('adam 17', 2)
('areas', 1)
('vector control', 4)
('experiments', 20)
('puromycin', 2)
('epidermal growth factor', 8)
('proteases', 10)
('cancer progression', 5)
('group', 4)
('ligand', 27)
('sodium', 2)
('presence', 7)
('edge', 1)
('forms', 4)
('absence', 7)
('decreased', 1)
('weeks', 7)
('dmso', 5)
('immunoblot', 15)
('cell invasion', 29)
('fourth', 2)
('material', 4)
('vitro', 15)
('effects', 8)
('compound', 10)
('not', 61)
('killed', 2)
('horseradish peroxidase', 2)
('instructions', 2)
('term', 33)
('calipers', 2)
('control condition', 4)
('goat', 4)
('magnitude', 4)
('mode', 11)
('mrna', 6)
('molecular basis', 2)
('interfering', 6)
('mean', 7)
('ag1478', 44)
('generation', 2)
('mda', 93)
('diphtheria toxin', 6)
('attenuation', 2)
('proteolysis', 1)
('er', 1143)
('negative regulation', 4)
('mediates', 11)
('thrombin', 257)
('increase', 71)
('kinase activity', 39)
('mammary fat pad', 27)
('hill', 4)
('induced', 167)
('induction', 2)
('eagle', 2)
('2 mm', 2)
('mechanisms', 2)
('free', 4)
('formation', 3)
('3t3 cells', 2)
('times', 9)
('filter', 2)
('tumor growth', 47)
('orca', 2)
('adp ribosylation', 4)
('invasive growth', 4)
('u6', 2)
('encoding', 4)
('number', 1)
('nacl', 2)
('one', 40)
('par2', 18)
('densitometry', 4)
('mammary', 35)
('noma', 161)
('introduction', 1)
('attenuated', 4)
('tace', 6)
('stimulation', 2)
('molecular', 3)
('final', 7)
('pathogen', 2)
('basal', 3)
('signaling', 81)
('mediators', 2)
('pertussis toxin', 17)
('population', 2)
('coagulant', 1)
('roles', 2)
('amide', 4)
('patients', 3)
('treated', 50)
('plasmin', 1)
('rad', 6)
('growth factors', 2)
('san', 4)
('hepes', 4)
('membranes', 5)
('ram', 5)
('1 week', 4)
('further', 6)
('cell surface', 8)
('cell types', 4)
('efficient', 8)
('mechanism', 27)
('potential', 1)
('objective', 2)
('short hairpin rna', 4)
('added', 7)
('multiple', 9)
('invasive breast cancer', 10)
('normal', 14)
('buffer', 4)
('edta', 2)
('matrix metalloprotease', 1)
('retroviruses', 2)
('complexes', 7)
('significant', 21)
('phase', 2)
('intrinsic', 1)
('pages', 2)
('disease', 8)
('peptides', 2)
('trafficking', 2)
('polyclonal antibody', 4)
('pd153035', 11)
('erbb', 338)
('sigma', 2)
('heterodimerization', 2)
('h\\&e', 7)
('german', 2)
('cardiac hypertrophy', 3)
('invasive breast carcinoma', 68)
('based', 1)
('kinase', 55)
('institution', 2)
('enzyme', 3)
('experiment', 23)
('metalloprotease', 36)
('factor', 43)
('\\/ml', 11)
('extracellular', 4)
('plate', 8)
('peptide', 24)
('dependent', 31)
('preferred', 2)
('breast', 209)
('matrigel', 4)
('untreated', 11)
('target', 9)
('mitogen-activated protein kinase', 3)
('tumors', 11)
('transferrin', 2)
('microscope', 2)
('crm197', 8)
('activity', 81)
('release', 12)
('g-protein-coupled receptors', 2)
('crm', 11)
('dimerization', 3)
('receptor tyrosine kinases', 3)
('anchored', 2)
('cytoplasmic', 1)
('result', 13)
('enhanced', 2)
('staining', 6)
('protein kinase c', 2)
('ability', 4)
('tumor microenvironment', 4)
('capacity', 4)
('xenograft model', 8)
('sites', 6)
('various', 13)
('membrane', 7)
('eosin', 5)
('therapies', 1)
('responses', 5)
('fold', 25)
('rapid', 4)
('extent', 10)
('orthovanadate', 2)
('reverse', 4)
('agonist', 25)
('equal', 2)
('gpcr', 14)
('coated', 2)
('embedding', 2)
('contribution', 10)
('expression', 43)
('inositol phosphates', 4)
('erbb2', 205)
('erbb3', 11)
('erbb1', 1)
('animal studies', 2)
('erbb4', 1)
('invasive', 96)
('ca', 397)
('normal breast', 6)
('packaging', 2)
('tgf', 3)
('sequences', 2)
('targeting', 6)
('7a', 4)
('addition', 16)
('protease inhibitor', 6)
('intracellular', 3)
('three', 13)
('reduction', 18)
('1 mm', 4)
('transformed', 2)
('monoclonal', 2)
('pm', 2)
('6a', 4)
('carboxyl', 2)
('mcf', 3)
('fibroblast', 30)
('representative', 11)
('scid mice', 2)
('ligands', 6)
('present', 22)
('p2', 9)
('p1', 27)
('reciprocal', 9)
('1 h', 6)
('2\\+', 2)
('intracellular signaling pathway', 1)
('sirna', 28)
('unpaired', 2)
('formalin', 2)
('va', 628)
('mutant', 4)
('bovine serum albumin', 2)
('binding', 3)
('vu', 1)
('partner', 2)
('technology', 4)
('diseases', 3)
('breast cancer cell', 6)
('different', 4)
('media', 55)
('cross', 2)
('stimulated', 72)
('complex', 9)
('high frequency', 4)
('plates', 2)
('several', 5)
('higher', 4)
('week', 30)
('independent', 9)
('nih', 17)
('extended', 1)
('elicits', 1)
('core facility', 2)
('american type culture collection', 2)
('i-', 34)
('cell signaling', 2)
('robust', 4)
('tyrosine kinase activity', 4)
('antibodies', 8)
('well', 20)
('nude mouse', 1)
('materials', 1)
('inactivation', 6)
('laboratories', 4)
('left', 9)
('dose', 4)
('inactive', 7)
('breast cancers', 4)
('human', 11)
('previous', 30)
('loading', 1)
('cancer', 37)
('ny', 8)
('unc lineberger comprehensive cancer center', 2)
('treatment', 9)
('metalloprotease activity', 20)
('hind', 2)
('ca2\\+', 2)
('bio', 12)
('increased', 10)
('format', 5)
('survival', 3)
('cell lysate', 5)
('period', 4)
('early', 16)
('kinase inhibitor', 4)
('increases', 7)
('inhibition', 12)
('five', 2)
('sequencing', 2)
('nih 3t3 cells', 2)
('erbb2 signaling', 6)
('histopathology', 2)
('loss', 5)
('signal', 100)
('mcf7', 1)
('specific', 38)
('chamber', 4)
('loop', 4)
('reduced', 5)
('supplement kit', 2)
('signaling molecule', 1)
('right', 7)
('old', 33)
('methods', 1)
('sequence', 10)
('hydrocortisone', 2)
('growth', 64)
('duration', 4)
('subtypes', 2)
('intact', 14)
('breast carcinoma', 156)
('fibroblasts', 20)
('tyrosine phosphorylation', 51)
('p44', 10)
('supplementary material', 1)
('bottom', 2)
('critical', 59)
('retro', 4)
('icr', 8)
('price', 4)
('bd', 2)
('core', 2)
('data analysis', 2)
('patient', 5)
('2b', 4)
('equivalent', 2)
('conformation', 1)
('pressure', 2)
('metastatic', 18)
('glycerol', 2)
('adam17', 4)
('heparin', 12)
('comparison', 2)
('herceptin', 1)
('reactive oxygen species', 2)
('tumor', 86)
('concentrations', 17)
('antibody', 24)
('block', 4)
('software', 2)
('transactivation', 233)
('facility', 4)
('image', 3)
('functional', 4)
('receptor', 29)
('female', 8)
('treatment options', 1)
('\\/h', 12)
('initial', 1)
('clinical', 1)
('low', 23)
('breast cancer', 33)
('tyrosine', 61)
('function', 26)
('starve', 10)
('medium', 19)
('form', 23)
('secreted', 28)
('triton x-100', 2)
('metastatic breast carcinoma', 6)
('volume', 2)
('hi', 150)
('link', 5)
('sustained', 17)
('mice', 29)
('promote', 29)
('cells', 297)
('vivo', 27)
('similar', 26)
('human breast tumors', 2)
('metastasis', 10)
('al', 616)
('immunoprecipitation', 10)
('epithelial', 14)
('myo', 4)
('statistical significance', 2)
('sligkv', 7)
('kidney', 3)
('functions', 3)
('nm', 25)
('amounts', 4)
('corporation', 2)
('nc', 269)
('field', 2)
('prism', 2)
('role', 59)
('phenol', 2)
('digital', 2)
('implant', 27)
('immunoprecipitate', 7)
('nonspecific', 7)
('generated', 15)
('important', 20)
('pathways', 4)
('isoproterenol', 2)
('lane', 12)
('kinetics', 4)
('persistent', 35)
('time course', 4)
('mass', 2)
('biotechnology', 2)


total: 695('', 97221)
('kidney diseases', 2)
('global', 4)
('activated', 27)
('resistance', 1)
('four', 6)
('gpcrs', 7)
('trastuzumab', 3)
('dish', 8)
('animal', 6)
('epithelial cells', 14)
('pretreatment', 4)
('environment', 6)
('xenografts', 3)
('crystal violet', 2)
('th', 1239)
('drug discovery', 2)
('endogenous', 4)
('hill', 4)
('anti-erbb2', 5)
('2 h', 9)
('activation', 319)
('nodules', 4)
('orthotopic', 8)
('induce', 197)
('1\xe2\x80\x934', 4)
('g i', 49)
('cellular', 54)
('difference', 3)
('condition', 34)
('chapel', 4)
('progression', 13)
('signal', 100)
('deficient', 66)
('list', 2)
('prolonged', 10)
('implants', 1)
('melanoma cell', 2)
('form', 23)
('-2', 95)
('small', 6)
('biological', 2)
('control\\.', 3)
('gm6001', 21)
('upper', 5)
('molecules\\.', 1)
('eagle', 2)
('197', 11)
('guidelines', 2)
('modified', 2)
('recruitment', 1)
('invaded', 3)
('insertion', 4)
('agonists', 3)
('her2', 12)
('acid', 2)
('elisa', 3)
('residue', 1)
('sub', 38)
('section', 12)
('cell', 405)
('3h', 8)
('phosphotyrosine', 2)
('new', 5)
('contrast', 12)
('dimerization', 3)
('-agauuagucuccaucaaua-3', 2)
('bt549', 9)
('metastases', 4)
('chemiluminescence', 2)
('groups', 2)
('3\\.0', 4)
('active', 18)
('based', 1)
('legend', 1)
('104', 4)
('box', 3)
('trans', 271)
('study', 12)
('amount', 5)
('insulin', 2)
('activation\\.', 17)
('reagents', 2)
('studies', 42)
('\\/sub', 4)
('glycerol', 2)
('psilencer', 4)
('family', 5)
('va', 628)
('egfr', 224)
('marked', 12)
('highly', 8)
('5\xe2\x80\x936', 4)
('mutant', 4)
('mouse mammary fat pad', 4)
('roles', 2)
('morphology', 1)
('pore size', 2)
('p44', 10)
('experiments\\.', 11)
('use', 57)
('usa', 10)
('positive', 10)
('ctrl', 1)
('two', 5)
('camera', 2)
('6', 105)
('fibroblast-secreted', 4)
('0\\%', 3)
('populations', 2)
('composite', 2)
('transient', 6)
('rabbit', 2)
('insertion sequence', 2)
('iii', 4)
('insights', 2)
('town', 2)
('sample', 2)
('mb', 375)
('ml', 11)
('work', 2)
('cancer patient', 1)
('cm2', 2)
('hydrolysis', 10)
('phosphoinositide', 10)
('erk1\\/2', 53)
('following', 16)
('inhibitor', 18)
('-ctacgtccaggagcgcacc-3', 2)
('10\\%', 2)
('proteolytic', 16)
('control', 92)
('telomerase', 2)
('par10', 1)
('figure', 160)
('process', 22)
('bovine pituitary extract', 2)
('invitrogen\\.', 2)
('agent', 8)
('high', 18)
('sense', 2)
('nonmetastatic', 2)
('serum', 18)
('mapk', 10)
('s1', 1)
('six', 2)
('ng\\/ml', 2)
('1', 766)
('flank', 4)
('toxin', 23)
('fourth', 2)
('optimal', 4)
('pathway', 9)
('30 min', 3)
('diphtheria toxin', 6)
('cocktail', 2)
('transforming', 1)
('humanized', 1)
('residues', 1)
('ix71', 2)
('polycarbonate', 2)
('mediated', 10)
('invasion', 133)
('data', 36)
('response', 10)
('ectopic expression', 3)
('-thrombin', 2)
('fibroblast-conditioned', 5)
('overexpression', 2)
('matrigel\\.', 2)
('lines', 7)
('adp ribosylation', 4)
('deterioration', 1)
('hb-egf', 10)
('anti-epidermal', 1)
('egf', 274)
('family members', 4)
('metastatic breast cancer', 9)
('photoshop', 2)
('shrna', 31)
('staining', 6)
('thrombin-', 105)
('adam 17', 2)
('areas', 1)
('vector control', 4)
('unc lineberger comprehensive cancer center', 2)
('crm197', 8)
('sirna-treated', 5)
('puromycin', 2)
('epidermal growth factor', 8)
('proteases', 10)
('cancer progression', 5)
('group', 4)
('ligand', 27)
('termed', 5)
('presence', 7)
('edge', 1)
('forms', 4)
('absence', 7)
('tfllrnpndk', 18)
('weeks', 7)
('dmso', 5)
('immunoblot', 15)
('5\\.1', 4)
('diseases', 3)
('material', 4)
('vitro', 15)
('effects', 8)
('compound', 10)
('not', 61)
('killed', 2)
('horseradish peroxidase', 2)
('instructions', 2)
('term', 33)
('calipers', 2)
('control condition', 4)
('proteins', 14)
('goat', 4)
('magnitude', 4)
('mode', 11)
('mrna', 6)
('molecular basis', 2)
('mouse', 7)
('interfering', 6)
('mean', 7)
('ag1478', 44)
('generation', 2)
('mda', 93)
('toxin-treated', 4)
('fibronectin', 2)
('attenuation', 2)
('cells\\.', 36)
('er', 1143)
('negative regulation', 4)
('mediates', 11)
('matrix', 1)
('factors', 30)
('thrombin', 257)
('increase', 71)
('kinase activity', 39)
('mammary fat pad', 27)
('immunodeficient', 17)
('induced', 167)
('induction', 2)
('pa317', 2)
('2 mm', 2)
('mechanisms', 2)
('mmp', 2)
('free', 4)
('treatments', 3)
('formation', 3)
('members', 4)
('3t3 cells', 2)
('g', 1575)
('times', 9)
('filter', 2)
('tumor growth', 47)
('factor-', 1)
('mice\\.', 10)
('orca', 2)
('-aaauuccaguggccaucaa-3', 2)
('invasive growth', 4)
('u6', 2)
('encoding', 4)
('number', 1)
('nacl', 2)
('one', 40)
('deplete', 4)
('par2', 18)
('par1', 271)
('densitometry', 4)
('anti-phosphotyrosine', 2)
('\xc3\x97', 18)
('mammary', 35)
('media\\.', 2)
('noma', 161)
('findings', 21)
('introduction', 1)
('attenuated', 4)
('tgf-', 3)
('tace', 6)
('stimulation', 2)
('molecular', 3)
('final', 7)
('pathogen', 2)
('discussion', 2)
('basal', 3)
('heterodimeric', 7)
('pars', 4)
('signaling', 81)
('mediators', 2)
('pertussis toxin', 17)
('population', 2)
('epidermal', 8)
('b', 2112)
('coagulant', 1)
('17', 8)
('amide', 4)
('breast cancer', 33)
('patients', 3)
('assays', 2)
('pertussis', 17)
('treated', 50)
('kinase-1', 3)
('plasmin', 1)
('and', 482)
('rad', 6)
('growth factors', 2)
('san', 4)
('7a', 4)
('membranes', 5)
('ram', 5)
('signal-regulated', 3)
('1 week', 4)
('further', 6)
('cell surface', 8)
('protein kinase c', 2)
('cell types', 4)
('efficient', 8)
('stromal', 8)
('mechanism', 27)
('potential', 1)
('ag1478-treated', 1)
('anti\\-phospho\\-p44\\/42', 5)
('short hairpin rna', 4)
('added', 7)
('multiple', 9)
('invasive breast cancer', 10)
('normal', 14)
('buffer', 4)
('edta', 2)
('matrix metalloprotease', 1)
('retroviruses', 2)
('complexes', 7)
('shown\\.', 1)
('carcinoma', 156)
('rho', 10)
('phase', 2)
('comparison', 2)
('intrinsic', 1)
('pages', 2)
('-ggaagaagccuuauuggua-3', 2)
('24-well', 8)
('disease', 8)
('peptides', 2)
('trafficking', 2)
('nonspecific', 7)
('pd153035', 11)
('erbb', 338)
('sigma', 2)
('heterodimerization', 2)
('h\\&e', 7)
('german', 2)
('cardiac hypertrophy', 3)
('invasive breast carcinoma', 68)
('par1\\.', 4)
('expression\\.', 8)
('protease-activated', 7)
('shrna-expressing', 18)
('anti-egfr', 4)
('i\\/o', 26)
('kinase', 55)
('receptors', 2)
('institution', 2)
('enzyme', 3)
('experiment', 23)
('metalloprotease', 36)
('factor', 43)
('\\/ml', 11)
('extracellular', 4)
('plate', 8)
('peptide', 24)
('dependent', 31)
('preferred', 2)
('12', 13)
('breast', 209)
('matrigel', 4)
('untreated', 11)
('target', 9)
('mitogen-activated protein kinase', 3)
('hematoxylin', 5)
('tumors', 11)
('transferrin', 2)
('heparin-binding-egf', 1)
('microscope', 2)
('experiments', 20)
('activity', 81)
('release', 12)
('g-protein-coupled receptors', 2)
('crm', 11)
('electroporation', 4)
('receptor tyrosine kinases', 3)
('anchored', 2)
('cytoplasmic', 1)
('result', 13)
('enhanced', 2)
('g-protein-coupled', 2)
('\\/italic', 8)
('ability', 4)
('tumor microenvironment', 4)
('capacity', 4)
('xenograft model', 8)
('sites', 6)
('various', 13)
('membrane', 7)
('eosin', 5)
('therapies', 1)
('responses', 5)
('fold', 25)
('rapid', 4)
('extent', 10)
('c', 3343)
('orthovanadate', 2)
('reverse', 4)
('agonist', 25)
('sodium', 2)
('equal', 2)
('gpcr', 14)
('coated', 2)
('embedding', 2)
('contribution', 10)
('expression', 43)
('inositol phosphates', 4)
('erbb2', 205)
('erbb3', 11)
('erbb1', 1)
('animal studies', 2)
('erbb4', 1)
('invasive', 96)
('nontransformed', 1)
('anti\\-p44\\/42', 5)
('normal breast', 6)
('packaging', 2)
('tgf', 3)
('thrombin-induced', 76)
('sequences', 2)
('gm6001-treated', 4)
('targeting', 6)
('hepes', 4)
('addition', 16)
('protease inhibitor', 6)
('intracellular', 3)
('three', 13)
('reduction', 18)
('kinases', 3)
('conjugated', 2)
('7\\.0', 2)
('monoclonal', 2)
('pm', 2)
('6a', 4)
('carboxyl', 2)
('lanes', 12)
('mcf', 3)
('fibroblast', 30)
('representative', 11)
('decreased', 1)
('scid mice', 2)
('ligands', 6)
('present', 22)
('p2', 9)
('p1', 27)
('reciprocal', 9)
('1 h', 6)
('2\\+', 2)
('intracellular signaling pathway', 1)
('sirna', 28)
('unpaired', 2)
('formalin', 2)
('cell invasion', 29)
('tace\\/adam17', 4)
('bovine serum albumin', 2)
('\\/h', 12)
('binding', 3)
('surface', 8)
('receptor-1', 7)
('statistical significance', 2)
('vu', 1)
('partner', 2)
('protein', 23)
('technology', 4)
('breast cancer cell', 6)
('different', 4)
('mas', 2)
('invasion\\.', 43)
('cross', 2)
('stimulated', 72)
('complex', 9)
('high frequency', 4)
('plates', 2)
('several', 5)
('higher', 4)
('week', 30)
('independent', 9)
('nih', 17)
('extended', 1)
('elicits', 1)
('core facility', 2)
('american type culture collection', 2)
('i-', 34)
('cell signaling', 2)
('robust', 4)
('tyrosine kinase activity', 4)
('antibodies', 8)
('kinase inhibitor', 4)
('well', 20)
('nude mouse', 1)
('polyclonal', 6)
('materials', 1)
('corporation', 2)
('laboratories', 4)
('left', 9)
('invasiveness', 1)
('plates\\.', 2)
('mda-mb-231', 93)
('dose', 4)
('inactive', 7)
('breast cancers', 4)
('human', 11)
('previous', 30)
('tumor-generated', 4)
('loading', 1)
('cancer', 37)
('transcriptase', 2)
('ny', 8)
('\\>', 24)
('\\?', 71)
('\\<', 27)
('mediator', 6)
('transformed', 2)
('treatment', 9)
('metalloprotease activity', 20)
('hind', 2)
('\\.', 737)
('5', 102)
('ca', 397)
('\\(', 368)
('\\)', 367)
('ca2\\+', 2)
('bio', 12)
('carcinoma\\.', 35)
('increased', 10)
('format', 5)
('survival', 3)
('cell lysate', 5)
('period', 4)
('early', 16)
('objective', 2)
('increases', 7)
('inhibition', 12)
('five', 2)
('sequencing', 2)
('membrane-anchored', 2)
('nih 3t3 cells', 2)
('erbb2 signaling', 6)
('histopathology', 2)
('loss', 5)
('d', 3154)
('anti-rabbit', 2)
('mcf7', 1)
('fibroblasts', 20)
('hmecs', 7)
('loop', 4)
('reduced', 5)
('supplement kit', 2)
('signaling molecule', 1)
('right', 7)
('old', 33)
('methods', 1)
('sequence', 10)
('transwells', 2)
('hydrocortisone', 2)
('growth', 64)
('duration', 4)
('subtypes', 2)
('intact', 14)
('breast carcinoma', 156)
('specific', 38)
('tyrosine phosphorylation', 51)
('total', 3)
('supplementary material', 1)
('chamber', 4)
('critical', 59)
('retro', 4)
('serum-starved', 8)
('icr', 8)
('g-protein', 4)
('price', 4)
('bd', 2)
('core', 2)
('data analysis', 2)
('patient', 5)
('2b', 4)
('equivalent', 2)
('conformation', 1)
('pressure', 2)
('metastatic', 18)
('adam15', 2)
('adam17', 4)
('heparin', 12)
('src', 2)
('herceptin', 1)
('reactive oxygen species', 2)
('tumor', 86)
('concentrations', 17)
('antibody', 24)
('block', 4)
('software', 2)
('transactivation', 233)
('significant', 21)
('facility', 4)
('image', 3)
('functional', 4)
('erbb2\\/her2', 12)
('dishes\\.', 2)
('receptor', 29)
('female', 8)
('treatment options', 1)
('proteolysis', 1)
('mmp-1', 1)
('initial', 1)
('clinical', 1)
('low', 23)
('serum-deprived', 5)
('py99', 5)
('was', 132)
('tyrosine', 61)
('function', 26)
('starve', 10)
('medium', 19)
('pyk2', 2)
('secreted', 28)
('triton x-100', 2)
('vehicle', 6)
('metastatic breast carcinoma', 6)
('volume', 2)
('inactivation', 6)
('anti-par1', 3)
('hi', 150)
('link', 5)
('sustained', 17)
('mice', 29)
('promote', 29)
('cells', 297)
('control-treated', 4)
('vivo', 27)
('3t3', 17)
('similar', 26)
('human breast tumors', 2)
('sectioning', 4)
('metastasis', 10)
('al', 616)
('immunoprecipitation', 10)
('epithelial', 14)
('myo', 4)
('immunoblotting\\.', 1)
('sligkv', 7)
('kidney', 3)
('functions', 3)
('melanoma', 2)
('nm', 25)
('amounts', 4)
('assessed\\.', 8)
('nc', 269)
('par1-induced', 4)
('matrigel-coated', 2)
('noninvading', 2)
('field', 2)
('prism', 2)
('role', 59)
('par1-deficient', 45)
('digital', 2)
('implant', 27)
('media', 55)
('immunoprecipitate', 7)
('polyclonal antibody', 4)
('bottom', 2)
('generated', 15)
('important', 20)
('pathways', 4)
('erbb4\\.', 1)
('phenol', 2)
('isoproterenol', 2)
('lane', 12)
('e', 8335)
('1 mm', 4)
('mitogen-activated', 3)
('anti-py99', 3)
('kinetics', 4)
('persistent', 35)
('time course', 4)
('paraffin', 2)
('mass', 2)
('adam', 9)
('thrombin-stimulated', 25)
('biotechnology', 2)
